Target Name: UNC5D
NCBI ID: G137970
Review Report on UNC5D Target / Biomarker Content of Review Report on UNC5D Target / Biomarker
UNC5D
Other Name(s): PRO34692 | netrin receptor Unc5h4 | unc-5 homolog D | KIAA1777 | unc-5 netrin receptor D | UNC5D_HUMAN | Netrin receptor UNC5D (isoform 1) | FLJ16019 | Protein unc-5 homolog D | Unc5h4 | Unc-5 netrin receptor D, transcript variant 1 | protein unc-5 homolog D | Netrin receptor UNC5D | Protein unc-5 homolog 4 | protein unc-5 homolog 4 | UNC5D variant 1 | unc-5 homolog 4 | Unc-5 homolog 4 | UNC5H4

UNC5D as A Potential Drug Target for Various Diseases

UNC5D (Pro34692) is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and gastrointestinal tract. It is a member of the UNC family of proteins, which are known for their role in cell signaling and inflammation.

Recent studies have identified UNC5D as a potential drug target (or biomarker) for the treatment of various diseases, including cancer, diabetes, and neurological disorders. This is because UNC5D has been shown to play a role in the development and progression of these conditions, as well as in the regulation of immune responses and inflammation.

One of the key mechanisms by which UNC5D is involved in disease is its role in the regulation of inflammation. In addition to its role in the development of cancer, UNC5D has been shown to contribute to the development of autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis.

In addition to its role in inflammation, UNC5D has also been shown to be involved in the regulation of cell signaling and the development of cancer. For example, studies have shown that UNC5D can inhibit the activity of the protein PD-L1, which is involved in immune surveillance and has been implicated in the development of cancer.

Furthermore, UNC5D has also been shown to be involved in the regulation of cell division and the development of cancer. For instance, studies have shown that UNC5D can promote the growth and division of cancer cells, a process that is critical for their development.

In addition to its role in cancer development, UNC5D has also been shown to contribute to the regulation of other important cellular processes, including cell adhesion, migration, and the regulation of the immune response.

Overall, UNC5D is a protein that has the potential to be a valuable drug target or biomarker for the treatment of a wide range of diseases. Its role in the regulation of inflammation, cell signaling, and cancer development makes it an attractive target for the development of new therapies. Further research is needed to fully understand the mechanisms of UNC5D's role in disease and to develop effective treatments based on this protein.

Protein Name: Unc-5 Netrin Receptor D

Functions: Receptor for the netrin NTN4 that promotes neuronal cell survival (By similarity). Plays a role in cell-cell adhesion and cell guidance. Receptor for netrin involved in cell migration. Plays a role in axon guidance by mediating axon repulsion of neuronal growth cones in the developing nervous system upon ligand binding (By similarity). May play a role in apoptosis in response to DNA damage (PubMed:24691657). It also acts as a dependence receptor required for apoptosis induction when not associated with netrin ligand (PubMed:24519068). Mediates cell-cell adhesion via its interaction with FLRT3 on an adjacent cell (By similarity)

The "UNC5D Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about UNC5D comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

UNC79 | UNC80 | UNC93A | UNC93B1 | UNC93B2 | UNC93B3 | UNC93B5 | Uncharactered LOC400863 | Uncharacterized FLJ44790 | Uncharacterized LOC101927121, transcript variant X1 | Uncharacterized LOC101928822, transcript variant X1 | Uncharacterized LOC101929670, transcript variant X1 | Uncharacterized LOC102723888, transcript variant X1 | Uncharacterized LOC102724782, transcript variant X2 | Uncharacterized LOC102724946, transcript variant X3 | Uncharacterized LOC105371833, transcript variant X2 | Uncharacterized LOC105372229, transcript variant X1 | Uncharacterized LOC105373166, transcript variant X2 | Uncharacterized LOC105373806, transcript variant X1 | Uncharacterized LOC105374567, transcript variant X2 | Uncharacterized LOC105374812, transcript variant X2 | Uncharacterized LOC105375163, transcript variant X1 | Uncharacterized LOC105376875, transcript variant X2 | Uncharacterized protein BC001742 | Uncharacterized protein FLJ23867 | Uncharacterized protein MGC16142 | Uncharacterized protein MGC27345 | UNCX | UNG | Uniplex complex | UNK | UNKL | UNQ9370 | UOX | UPB1 | UPF1 | UPF2 | UPF3A | UPF3B | UPK1A | UPK1A-AS1 | UPK1B | UPK2 | UPK3A | UPK3B | UPK3BL1 | UPP1 | UPP2 | UPRT | UQCC1 | UQCC2 | UQCC3 | UQCC4 | UQCC5 | UQCC6 | UQCR10 | UQCR10P1 | UQCR11 | UQCRB | UQCRBP1 | UQCRC1 | UQCRC2 | UQCRC2P1 | UQCRFS1 | UQCRFS1P1 | UQCRH | UQCRHL | UQCRQ | URAD | URAHP | URB1 | URB1-AS1 | URB2 | Urea transporter | URGCP | URGCP-MRPS24 | URI1 | Uridine phosphorylase | URM1 | UROC1 | UROD | UROS | USB1 | USE1 | USF1 | USF2 | USF3 | USH1C | USH1G | USH2A | USHBP1 | USO1 | USP1 | USP1-UAF1 complex | USP10 | USP11 | USP12 | USP12-AS1 | USP12-DT | USP13